ArticleFrontiers in oncology2022

Liver injury during durvalumab-based immunotherapy is associated with poorer patient survival: A retrospective analysis.

Linnea A Swanson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.